Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Naldemedine (S 297995) is a peripheral selective μ-opioid receptor antagonist being developed by Shionogi for the treatment of opioid-induced adverse reactions, including constipation, nausea, and vomiting. They are usually well tolerated, mainly with mild to moderate gastrointestinal side effects.
説明 | Naldemedine (S 297995) is a peripheral selective μ-opioid receptor antagonist being developed by Shionogi for the treatment of opioid-induced adverse reactions, including constipation, nausea, and vomiting. They are usually well tolerated, mainly with mild to moderate gastrointestinal side effects. |
別名 | S-297995, S297995, Naldemedine, S 297995, S297,995, S 297,995, S297,995;Naldemedine, S-297,995 |
分子量 | 570.64 |
分子式 | C32H34N4O6 |
CAS No. | 916072-89-4 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Naldemedine 916072-89-4 S-297995 S297995 S 297995 S297,995 S 297,995 S297,995;Naldemedine S-297,995 Inhibitor inhibitor inhibit